Filing Details
- Accession Number:
- 0001209191-21-028384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-26 18:13:28
- Reporting Period:
- 2021-04-22
- Accepted Time:
- 2021-04-26 18:13:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1322505 | Albireo Pharma Inc. | ALBO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741553 | Jason Duncan | C/O Albireo Pharma Inc. 10 Post Office Square, Suite 1000 Boston MA 02109 | Chief Legal Officer And Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-22 | 90 | $31.75 | 8,071 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-23 | 222 | $32.32 | 7,849 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- Represents 383 shares of common stock and 7,688 restricted stock units.
- Shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
- Represents 161 shares of common stock and 7,688 restricted stock units.
Billionaire Hedge Funds
